Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Ocera Therapeutics, Inc. | Financial_Report.xls |
| EX-31.1 - CEO CERTIFICATION SECTION 302 - Ocera Therapeutics, Inc. | ocrxexhibit31110k2014.htm |
| EX-31.2 - CFO CERTIFCATION SECTION 302 - Ocera Therapeutics, Inc. | ocrxexhibit31210k2014.htm |
| EX-32.1 - CEO CERTIFICATION SECTION 906 - Ocera Therapeutics, Inc. | ocrxexhibit32110k2014.htm |
| 10-K - OCERA 10-K 2014 - Ocera Therapeutics, Inc. | ocera10-k2014.htm |
| EX-23 - EXHIBIT 23.1 CONSENT OF INDEPENDENT AUDITORS - Ocera Therapeutics, Inc. | ocrxexhibit23110k2014.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Ocera Therapeutics, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Michael Byrnes, M.B.A., Chief Financial Officer and Treasurer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge that:
(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: | March 13, 2015 | By: | /s/Michael Byrnes |
Michael Byrnes | |||
Chief Financial Officer and Treasurer | |||
(Principal Financial and Accounting Officer) | |||